2023
Developing non-opioid therapeutics to alleviate pain among persons with opioid use disorder: a review of the human evidence
Oliveira D, Fontenele R, Weleff J, Sofuoglu M, De Aquino J. Developing non-opioid therapeutics to alleviate pain among persons with opioid use disorder: a review of the human evidence. International Review Of Psychiatry 2023, 35: 377-396. PMID: 38299655, PMCID: PMC10835074, DOI: 10.1080/09540261.2023.2229430.Peer-Reviewed Original ResearchOpioid agonist therapyOpioid use disorderNon-opioid analgesicsUse disordersNon-opioid analgesic therapyAlpha-2 adrenergic agonistsMajor public health concernGlial activation inhibitorNon-opioid therapeuticsNovel analgesic strategiesPotential of cannabinoidsPrior opioid exposureOpioid-dependent individualsOpioid-dependent populationsAbuse liability assessmentPublic health concernAnalgesic strategiesAgonist therapyAnalgesic therapyOpioid exposureOUD treatmentPharmacokinetic interactionsGABAergic drugsSignificant morbidityPain types
2015
VA Patients With High Numbers of Opioid Prescriptions
Petrakis I, Sofuoglu M, Rosenheck R. VA Patients With High Numbers of Opioid Prescriptions. Addictive Disorders & Their Treatment 2015, 14: 167-175. DOI: 10.1097/adt.0000000000000058.Peer-Reviewed Original ResearchHigh opioid useOpioid usePrescription opioid useOpioid prescriptionsOpioid groupOutpatient visitsHigher prescription opioid useVeterans Health Administration usersVeterans Health Administration patientsLogistic regressionDrug abuseMajor public health concernAntidepressant medication prescriptionMedical outpatient visitsOpioid prescription useEmergency room visitsComorbid drug useDrug use disordersForm of painPsychotropic medication usagePublic health concernConcomitant antidepressantsAntidepressant prescriptionsPsychotropic prescriptionsMedical illness
2008
Treatment of stimulant dependence
Sofuoglu M, Agath K, Kosten T. Treatment of stimulant dependence. 2008, 369-380. DOI: 10.1017/cbo9780511544392.021.Peer-Reviewed Original ResearchCognitive-behavioral approachSingle randomized control trialBehavioral approachStimulant dependenceContingency managementMisuse of substancesMajor public health concernPsychopharmacologic treatmentStimulant abuseTreatment programTreatment retentionDrug-free urineRandomized control trialYears of agePublic health concernCocaine abusersClass of agentsDopamine agentsUse of vouchersAnnual prevalencePharmacotherapeutic agentsControl trialAmphetamine abusersAmphetamine addictionHealth concern